Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions.

about

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.

P2860

Q28080752-C7D88DBF-5DAA-427E-898F-205E1F27BAB9 Q33440436-1A7A2524-FE4B-47B1-B193-D6DF18CF43E8

P2860

Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions.

Item

http://www.wikidata.org/entity/Q42245471

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Pattern and associated factors ...... ent-induced adverse reactions.

@en

Pattern and associated factors ...... ent-induced adverse reactions.

@nl

type

Item

label

Pattern and associated factors ...... ent-induced adverse reactions.

@en

Pattern and associated factors ...... ent-induced adverse reactions.

@nl

prefLabel

Pattern and associated factors ...... ent-induced adverse reactions.

@en

Pattern and associated factors ...... ent-induced adverse reactions.

@nl

P1476

Pattern and associated factors ...... ent-induced adverse reactions.

@en

P2093

Hossein Khalili

http://www.w3.org/2001/XMLSchema#string

Mehdi Ahadi-Barzoki

http://www.w3.org/2001/XMLSchema#string

Mohsen Nasiri-Toosi

http://www.w3.org/2001/XMLSchema#string

Saeedeh Ravi

http://www.w3.org/2001/XMLSchema#string

Simin Dashti-Khavidaki

http://www.w3.org/2001/XMLSchema#string

P2860

Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study

Global epidemiology of hepatitis C virus infection

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Diagnosis, management, and treatment of hepatitis C: an update

Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.

Factors regarding increase of platelet counts in chronic hepatitis C patients with sustained virological response to interferon-Relation to serum thrombopoietin levels.

Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.

Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.

Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin

P304

277-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2014.866091

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iman Karimzadeh

P577

2014-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259585366

http://www.w3.org/2001/XMLSchema#string

P698

24386997

http://www.w3.org/2001/XMLSchema#string

Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions.

about

P2860

P2860

Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698